exceptional service across specialties
The journey for patients with complex, hard-to-diagnose diseases can be long and challenging. Many spend years moving from one specialist to another before receiving a diagnosis, and managing treatment and related difficulties can be a daily struggle.
As a specialty pharmacy focused on supporting patients with these complex conditions, we are committed to guiding you through every stage of theat journey, both clinically and administratively to help you achieve the best possible outcomes. Out Therapy Care Teams are extensively trained in each condition we support, allowing us to tailor our approach to meet the unique needs of every patient. Learn more about the conditions and therapies we support below.
Asthma & Allergy
Asthma is a long term condition causing inflammation to the airways and making it difficult to breathe.
Bleeding Disorders
There are several bleeding disorders such as Hemophilia, Von Willebrand disease, and several clotting factors deficiencies.
Hepatitis B
Chronic Hepatitis B is a virus transmitted by bodily fluids that can lead to serious liver damage.
HIV
HIV is a serious viral infection that attacks the body’s immune system and if left untreated can seriously impair the body’s ability to fight off infections.
Inflammatory Bowel Disease
IBD is inflammation of the GI tract manifesting in either Crohn’s disease or Ulcerative colitis.
Oncology
Oncology involves several different types of cancer and can affect multiple areas of the body.
Pulmonary Hypertension
PH is a rare condition in which high blood pressure occurs specifically in the lungs.
Sickle Cell Disease
Sickle cell disease is caused by a hereditary condition affecting the red blood cells.
Search by Drug
Search by Condition or Specialty
- Drug: tenofovir disoproxil fumarate
Manufacturer: misc
Route of Administration: Oral
- Site of Care: Outpatient
- Approved Indication:
- in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 10 kg
- treatment of chronic hepatitis B in adults and pediatric patients 2 years and older weighing at least 10 kg
- Disease: chronic viral hepatitis B, HIV
- Therapeutic Area: Infectious disease, Gastroenterology, Hepatology
Enrollment Form Link: N/A
Phone Number: N/A
Fax Number: N/A
Product Website: N/A
- Drug: Tremfya (guselkumab)
Manufacturer: Johnson & Johnson
Route of Administration: Intravenous, Subcutaneous
- Site of Care: Outpatient
- Approved Indication:
- treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy
- treatment of active psoriatic arthritis in adults
- treatment of moderately-to-severely active Crohn’s disease in adults
- treatment of moderately-to-severely active ulcerative colitis in adults
Disease: Crohn’s disease, plaque psoriasis, psoriatic arthritis, ulcerative colitis
Therapeutic Area: Gastroenterology, Rheumatology, Dermatology
- Enrollment Form Link: Enrollment Form
Phone Number: 844-4withMe (844-494-8463)
Fax Number: 800-600-7226
- Product Website: tremfya.com
- Drug: Trulance (plecanatide)
- Manufacturer: Salix Pharmaceuticals
Route of Administration: Oral
Site of Care: Outpatient
Approved Indication:
- treatment of irritable bowel syndrome with constipation in adults
- treatment of chronic idiopathic constipation in adults
- treatment of functional constipation in pediatric patients 6 to 17 years of age
Disease: irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC), functional constipation
Therapeutic Area: Gastroenterology
- Enrollment Form Link: N/A
- Phone Number: N/A
- Fax Number: N/A
- Product Website: linzess.com
- Drug: Tyvaso (treprostinil inhalation solution & powder)
- Manufacturer: United Therapeutics
Route of Administration: Inhalation
- Site of Care: Outpatient
- Approved Indication:
- pulmonary arterial hypertension (WHO group 1) to improve exercise ability
- pulmonary hypertension associated with interstitial lung disease (PH-ILD, WHO group 3) to improve exercise ability
- Disease: pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease (PH-ILD)
Therapeutic Area: Pulmonary
- Enrollment Form Link: Enrollment Form
- Phone Number: 1-844-864-8437
- Fax Number: 1-800-380-5294
- Product Website: tyvaso.com
- Drug: Udenyca (pegfilgrastim-cbqv)
- Manufacturer: Coherus BioSciences
Route of Administration: Subcutaneous
- Site of Care: Outpatient
Approved Indication:
- to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of febrile neutropenia
- to increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome)
Disease: neutropenia associated with myelosuppressive anti-cancer therapy, hematopoietic syndrome of acute radiation syndrome
Therapeutic Area: Hematology, Oncology
- Enrollment Form Link: Coherus Solutions
- Phone Number: 1-844-483-3692
- Fax Number: 1-877-226-6370
- Product Website: udenyca.com
- Drug: Uptravi (selexipag)
- Manufacturer: Johnson & Johnson
- Route of Administration: Oral
- Site of Care: Outpatient
- Approved Indication: treatment of pulmonary arterial hypertension (PAH, WHO group 1) to delay disease progression and reduce the risk of hospitalization for PAH
Disease: pulmonary arterial hypertension
Therapeutic Area: Pulmonary
- Enrollment Form Link: referral form
- Phone Number: 866-228-3546
- Fax Number: 866-279-0669
- Product Website: uptravi.com
- Drug: Velsipity (etrasimod)
- Manufacturer: Pfizer
Route of Administration: Oral
- Site of Care: Outpatient
Approved Indication: treatment of moderately-to-severely active ulcerative colitis in adults
- Disease: ulcerative colitis
- Therapeutic Area: Gastroenterology
- Enrollment Form Link: velsipity.com“>Velsipity for Me
- Phone Number: 1-800-350-3080
- Fax Number: 1-646-862-9655
- Product Website: velsipity.com
- Drug: Vemlidy (tenofovir alafenamide)
- Manufacturer: Gilead
Route of Administration: Oral
- Site of Care: Outpatient
- Approved Indication: treatment of chronic hepatitis B virus infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease
- Disease: chronic viral hepatitis B
Therapeutic Area: Infectious disease, Gastroenterology, Hepatology
- Enrollment Form Link: My Support Path
- Phone Number: 1-855-769-7284
Fax Number: N/A
- Product Website: vemlidy.com
- Drug: Viokace (pancrelipase)
- Manufacturer: Aptalis Pharma
Route of Administration: Oral
- Site of Care: Outpatient
- Approved Indication: in combination with a proton pump inhibitor, for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults
Disease: exocrine pancreatic insufficiency
Therapeutic Area: Gastroenterology
- Enrollment Form Link: N/A
- Phone Number: N/A
- Fax Number: N/A
- Product Website: N/A
- Drug: Vosevi (sofosbuvir/velpatasvir/voxilaprevir)
Manufacturer: Gilead
Route of Administration: Oral
- Site of Care: Outpatient
Approved Indication: treatment of adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis who have
- genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor
- genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor
Disease: chronic viral hepatitis C
Therapeutic Area: Infectious disease, Gastroenterology, Hepatology
- Enrollment Form Link: MySupportPath
Phone Number: N/A
- Fax Number: 1-855-298-8700
- Product Website: N/A